share_log

Regeneron Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Bassler Bonnie L

SEC ·  Aug 19, 2024 16:03
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more